» Articles » PMID: 20407217

Communicating Genetic and Genomic Information: Health Literacy and Numeracy Considerations

Overview
Specialties Genetics
Public Health
Date 2010 Apr 22
PMID 20407217
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Genomic research is transforming our understanding of the role of genes in health and disease. These advances, and their application to common diseases that affect large segments of the general population, suggest that researchers and practitioners in public health genomics will increasingly be called upon to translate genomic information to individuals with varying levels of health literacy and numeracy. This paper discusses the current state of research regarding public understanding of genetics and genomics, the influence of health literacy and numeracy on genetic communication, and behavioral responses to genetic and genomic information. The existing research suggests that members of the general public have some familiarity with genetic and genomic terms but have gaps in understanding of underlying concepts. Findings from the limited research base to date indicate that health literacy affects understanding of print and oral communications about genetic and genomic information. Numeracy is also likely to be an important predictor of being able to understand and apply this information, although little research has been conducted in this area to date. In addition, although some research has examined behavior change in response to the receipt of information about genetic risk for familial disorders and genomic susceptibility to common, complex diseases, the effects of health literacy and numeracy on these responses have not been examined. Potential areas in which additional research is needed are identified and practical suggestions for presenting numeric risk information are outlined. Public health genomics researchers and practitioners are uniquely positioned to engage in research that explores how different audiences react to and use genomic risk information.

Citing Articles

Perception of the Importance of Inherited Genetics and Lifestyle on the Development of Chronic Diseases: A UK Cross-Sectional Survey.

Hussain A, Santos-Merx L, Da Boit M Health Sci Rep. 2025; 8(1):e70324.

PMID: 39763582 PMC: 11702401. DOI: 10.1002/hsr2.70324.


A video intervention to improve patient understanding of tumor genomic testing in patients with cancer.

Veney D, Wei L, Toland A, Presley C, Hampel H, Padamsee T Cancer Med. 2024; 13(17):e70095.

PMID: 39258462 PMC: 11387988. DOI: 10.1002/cam4.70095.


Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities.

Walker M, Blackmore K, Chang A, Lambert-Cote L, Turgeon A, Antoniou A Cancers (Basel). 2024; 16(11).

PMID: 38893236 PMC: 11171515. DOI: 10.3390/cancers16112116.


The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors.

Henderson T, Allen M, Mim R, Egleston B, Fleisher L, Elkin E BMC Health Serv Res. 2024; 24(1):253.

PMID: 38414045 PMC: 10900774. DOI: 10.1186/s12913-024-10586-z.


Pharmacogenomic knowledge and awareness among diverse patients treated with angiotensin converting enzyme inhibitors.

Naik H, OConnor M, Sanderson S, Pinnell N, Dong M, Wiegand A Pharmacogenomics. 2023; 24(18):921-930.

PMID: 38054855 PMC: 10794943. DOI: 10.2217/pgs-2023-0191.


References
1.
Lipkus I . Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations. Med Decis Making. 2007; 27(5):696-713. DOI: 10.1177/0272989X07307271. View

2.
Hadley D, Jenkins J, Steinberg S, Liewehr D, Moller S, Martin J . Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. J Clin Oncol. 2008; 26(6):948-54. DOI: 10.1200/JCO.2007.13.0575. View

3.
Lerman C, Schnoll R, Munafo M . Genetics and smoking cessation improving outcomes in smokers at risk. Am J Prev Med. 2007; 33(6 Suppl):S398-405. PMC: 2170888. DOI: 10.1016/j.amepre.2007.09.006. View

4.
McBride C, Bepler G, Lipkus I, Lyna P, Samsa G, Albright J . Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev. 2002; 11(6):521-8. View

5.
Molster C, Charles T, Samanek A, OLeary P . Australian study on public knowledge of human genetics and health. Public Health Genomics. 2008; 12(2):84-91. DOI: 10.1159/000164684. View